Kymera Therapeutics (KYMR) PT Raised to $170 at Guggenheim
(Updated - August 31, 2026 7:11 AM EDT)
Guggenheim analyst Brad Canino raised the price target on Kymera Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Guggenheim analyst Brad Canino raised the price target on Kymera Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

